Akero Therapeutics (AKRO) had the highest return in September 2022 by a mid-cap US stock, returning 184%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | September 2022 | 183.99% |
Ideaya Biosciences (IDYA) | September 2022 | 50.71% |
New Gold (NGD) | September 2022 | 40.58% |
89bio (ETNB) | September 2022 | 31.89% |
Intapp (INTA) | September 2022 | 30.65% |
Compania de Minas Buenaventura SAA ADR (BVN) | September 2022 | 29.42% |
Wix (WIX) | September 2022 | 26.42% |
Immunitybio (IBRX) | September 2022 | 24.87% |
D-Wave Quantum (QBTS) | September 2022 | 24.33% |
International Seaways (INSW) | September 2022 | 21.17% |
Asana (ASAN) | September 2022 | 19.71% |
Bausch Health Companies (BHC) | September 2022 | 19.62% |
Melco Resorts & Entertainment (MLCO) | September 2022 | 18.39% |
Ero Copper (ERO) | September 2022 | 17.65% |
Xometry (XMTR) | September 2022 | 16.97% |
Penumbra (PEN) | September 2022 | 16.91% |
Freshpet (FRPT) | September 2022 | 16.6% |
Alphatec (ATEC) | September 2022 | 16.53% |
Weatherford International (WFRD) | September 2022 | 16.28% |
Nuvalent (NUVL) | September 2022 | 15.17% |
Workiva (WK) | September 2022 | 15.04% |
Apellis Pharmaceuticals (APLS) | September 2022 | 13.27% |
Transportadora de Gas del Sur SA ADR (TGS) | September 2022 | 12.67% |
Wingstop (WING) | September 2022 | 12.46% |
Tarsus Pharmaceuticals (TARS) | September 2022 | 12.19% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
